Adamas Pharmaceuticals In... (ADMS)
NASDAQ: ADMS
· Real-Time Price · USD
8.22
0.00 (0.00%)
At close: Apr 24, 2025, 3:47 PM
Adamas Pharmaceuticals Revenue Breakdown
Period Ending | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
---|---|---|---|
Product Revenue | 71.17M | 54.64M | 34.05M |
Product Revenue Growth | +30.25% | +60.48% | n/a |
Royalty Revenue | 3.29M | n/a | n/a |
Royalty Revenue Growth | n/a | n/a | n/a |
Operating Expense Breakdown
Period Ending | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selling, General, and Administrative Revenue | 29.73M | 29.15M | 26.64M | 32.99M | 26.12M | 23.18M | 24.55M | 30.29M | 31.18M | 25.22M | 27.69M | 27.58M | 27.49M | 27.7M | 26.36M | 22.99M | 16.06M | 13.12M | 9.14M | 8.28M | 7.34M | 8.06M | 6.64M | 6.89M | 5.8M | 5.85M | 4.92M |
Selling, General, and Administrative Revenue Growth | +1.99% | +9.43% | -19.26% | +26.31% | +12.70% | -5.60% | -18.93% | -2.87% | +23.65% | -8.93% | +0.38% | +0.33% | -0.75% | +5.07% | +14.68% | +43.11% | +22.49% | +43.43% | +10.39% | +12.79% | -8.86% | +21.34% | -3.61% | +18.73% | -0.74% | +18.85% | n/a |
Research and Development Revenue | 1.23M | 1.45M | 1.81M | 2.4M | 2.33M | 2.55M | 2.46M | 5.18M | 6.04M | 8.6M | 10.21M | 10.6M | 11.71M | 9.81M | 7.19M | 6.45M | 6.46M | 7.18M | 7.09M | 7.05M | 7.44M | 9.22M | 7.52M | 9.7M | 9.96M | 8.71M | 7.53M |
Research and Development Revenue Growth | -15.40% | -20.09% | -24.44% | +2.79% | -8.51% | +3.45% | -52.41% | -14.27% | -29.73% | -15.82% | -3.61% | -9.50% | +19.41% | +36.42% | +11.53% | -0.22% | -9.99% | +1.24% | +0.58% | -5.24% | -19.37% | +22.63% | -22.43% | -2.64% | +14.42% | +15.56% | n/a |